4.1 Article

No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Medicine, General & Internal

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults 2020 Recommendations of the International Antiviral Society-USA Panel

Michael S. Saag et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Medicine, General & Internal

HIV-Associated Cancers and Related Diseases

Robert Yarchoan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Infectious Diseases

A large French prospective cohort of HIV-infected patients: the Nadis Cohort

P. Pugliese et al.

HIV MEDICINE (2009)

Letter Medicine, General & Internal

HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load

Toby Maurer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Oncology

Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma

M Bower et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

Review Oncology

Antitumour effects of antiretroviral therapy

P Monini et al.

NATURE REVIEWS CANCER (2004)

Article Biochemistry & Molecular Biology

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

C Sgadari et al.

NATURE MEDICINE (2002)